We are live on
!
Find out more
BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
14 hedge funds and large institutions have $2.77M invested in Better Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,580% more call options, than puts
Call options by funds: $420K | Put options by funds: $25K
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
61% less capital invested
Capital invested by funds: $7.16M → $2.77M (-$4.39M)
Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
2
Closed
5
Calls
$420K
Puts
$25K
Net Calls
+$395K
Net Calls Change
+$97K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$157K |
| 2 |
BlackRock
New York
|
+$127K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$114K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$82.2K |
| 5 |
State Street
Boston,
Massachusetts
|
+$75.6K |
